Biodelivery Sciences International Inc (BDSI) Return on Equity ROE from the fourth quarter 2021 to fourth quarter 2020 and annually, average high and low, overall ranking from Dec 31 2021 to Dec 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biodelivery Sciences International Inc   (NASDAQ: BDSI)

Biodelivery Sciences International Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Biodelivery Sciences International Inc in the fourth quarter 2021?
Biodelivery Sciences International Inc achieved a return on average equity (ROE) of 63.64 % in its fourth quarter 2021 a new company high.

ROE has advanced compared to 27.47% in the third quarter 2021, due to net income growth.

Within the Major Pharmaceutical Preparations industry 18 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 206, from total ROE ranking in the third quarter 2021 at 602.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter
Y / Y Equity Change 73.53 % 28.04 % 34.38 % 42.13 % -
Y / Y Net Income Change 526.56 % -28.92 % 678.03 % 5.46 % -
Net Income (TTM) in Millions 85 31 34 26 26
Return On Equity (TTM) 63.64 % 27.47 % 31.75 % 26.13 % 28.14 %
BDSI's Total Ranking # 206 # 602 # 497 # 509 # 377
Equity (TTM) in Millions 188 123 114 109 108
Seq. Equity Change 52.98 % 7.77 % 4.65 % 0.57 % 12.88 %
Seq. Net Income Change 858.01 % -26.42 % 73.08 % -48.64 % 8.68 %

Back to BDSI Management Effectiveness >> BDSI's 5 Years Annual ROE >> Compare BDSI ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 19
Sector # 39
Overall # 206

Return On Equity Statistics
High Average Low
63.64 %
-289.97 %
-7277.83 %
(Dec 31 2021)   (Dec 31 2016)





BDSI Annual Return On Equity (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Equity in Millions 188 108 70 30 9
Y / Y Equity Change 73.53 % 55.14 % 134.56 % 235.05 % -
Net Income in Millions 85 26 -15 -34 5
Y / Y Net Income Change 230.05 % - - - -
Return On Equity 45.18 % 23.76 % -21.94 % -113.87 % 59.54 %

Back to BDSI Management Effectiveness >> BDSI's 5 Years Annual ROE >> Compare BDSI ROE to its Competitors




Annual Roe Comment
In 2021 ROE improved to 45.18 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BDSI's' Return on Equity at Yahoo Finance
BDSI's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BDSI's Competitors
Subscribers only: Roe for Biodelivery Sciences International Inc 's Suppliers
Subscribers only: Return On Equity for BDSI's Customers




Companies with similar Return On Equity at Dec 31 2021, within Healthcare Sector ROE
Sinovac Biotech Ltd  156.97 %
Journey Medical Corp  145.12 %
Moderna Inc   140.21 %
Tivity Health Inc   130.89 %
Altamira Therapeutics Ltd   130.39 %
Ironwood Pharmaceuticals inc   116.93 %
Vyne Therapeutics Inc   106.54 %
Galmed Pharmaceuticals Ltd   106.24 %
Idexx Laboratories Inc  102.84 %
Tenet Healthcare Corp  100.51 %
Molecular Templates Inc   96.66 %
Agios Pharmaceuticals Inc   95.73 %
Davita Inc   93.93 %
Maravai Lifesciences Holdings Inc   87.13 %
Biontech Se  86.54 %
Abbvie Inc   83.48 %
Vivos Therapeutics Inc   74.61 %
Cryo cell International Inc   73.81 %
Amgen Inc   72.53 %
Eli Lilly And Company  72.32 %
Biomx Inc  71.20 %
Novo Nordisk A  70.56 %
Innoviva Inc   69.98 %
Retractable Technologies Inc  69.81 %
Dynavax Technologies Corporation  64.86 %
Uniqure N v   64.35 %
Biodelivery Sciences International Inc   63.64 %
Glucotrack Inc   60.05 %
Ovid Therapeutics Inc   59.58 %
Silo Pharma Inc  57.39 %

Date modified: 2026-09-08T15:10:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.